Newsroom

  • Category

  • By Date

  • Press Release

    10 April 25

    CuraTeQ Biologics successfully completes Phase I study for Denosumab biosimilar

    Read more
  • Press Release

    15 March 24

    CuraTeQ Biologics successfully completes Phase 1 trial for Omalizumab biosimilar

    Read more